Matches any text strings used to describe a molecule.
Systematic Name, Synonym, Trade Name, Registry Number, SMILES, InChI or CSID

Systematic names 1,2-dihydroxybenzene
Synonyms AIBN
Trade names Aspirin
Registry numbers 7732-18-5
SMILES O=C(OCC)C
InChl InChI=1/CH4/h1H4
Search Hits Limit:
Single/Multi-component
Isotopically Labeled
Additional Filters

Found 10 results

Search term: YYFJXWVWFNDEQO (Found by InChIKey (skeleton match))
IDStructureMolecular FormulaMolecular Weight# of Data Sources# of References# of PubMed# of RSC
3595351

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C21H27NO5S/c1-11-9-14(15(20(24)25)10-12(11)2)18(23)22-19-17(21(26)27-3)13-7-5-4-6-8-16(13)28-19/h14-15H,4-10H2,1-3H3,(H,22,23)(H,24,25)
C21H27NO5S405.50778231700
861757

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C21H27NO5S/c1-11-9-14(15(20(24)25)10-12(11)2)18(23)22-19-17(21(26)27-3)13-7-5-4-6-8-16(13)28-19/h14-15H,4-10H2,1-3H3,(H,22,23)(H,24,25)/t14-,15+/m0/s1
C21H27NO5S405.50782100
861759

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C21H27NO5S/c1-11-9-14(15(20(24)25)10-12(11)2)18(23)22-19-17(21(26)27-3)13-7-5-4-6-8-16(13)28-19/h14-15H,4-10H2,1-3H3,(H,22,23)(H,24,25)/t14-,15-/m1/s1
C21H27NO5S405.50782100
861760

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C21H27NO5S/c1-11-9-14(15(20(24)25)10-12(11)2)18(23)22-19-17(21(26)27-3)13-7-5-4-6-8-16(13)28-19/h14-15H,4-10H2,1-3H3,(H,22,23)(H,24,25)/t14-,15-/m0/s1
C21H27NO5S405.50782100
861762

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C21H27NO5S/c1-11-9-14(15(20(24)25)10-12(11)2)18(23)22-19-17(21(26)27-3)13-7-5-4-6-8-16(13)28-19/h14-15H,4-10H2,1-3H3,(H,22,23)(H,24,25)/t14-,15+/m1/s1
C21H27NO5S405.50782100
5414566

Charge

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C21H27NO5S/c1-11-9-14(15(20(24)25)10-12(11)2)18(23)22-19-17(21(26)27-3)13-7-5-4-6-8-16(13)28-19/h14-15H,4-10H2,1-3H3,(H,22,23)(H,24,25)/p-1/t14-,15-/m1/s1
C21H26NO5S404.50042200
5414567

Charge

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C21H27NO5S/c1-11-9-14(15(20(24)25)10-12(11)2)18(23)22-19-17(21(26)27-3)13-7-5-4-6-8-16(13)28-19/h14-15H,4-10H2,1-3H3,(H,22,23)(H,24,25)/p-1/t14-,15-/m0/s1
C21H26NO5S404.50041100
5640106

Charge

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C21H27NO5S/c1-11-9-14(15(20(24)25)10-12(11)2)18(23)22-19-17(21(26)27-3)13-7-5-4-6-8-16(13)28-19/h14-15H,4-10H2,1-3H3,(H,22,23)(H,24,25)/p-1/t14-,15+/m1/s1
C21H26NO5S404.50041100
5640107

Charge

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C21H27NO5S/c1-11-9-14(15(20(24)25)10-12(11)2)18(23)22-19-17(21(26)27-3)13-7-5-4-6-8-16(13)28-19/h14-15H,4-10H2,1-3H3,(H,22,23)(H,24,25)/p-1/t14-,15+/m0/s1
C21H26NO5S404.50041100
3935208

Charge

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C21H27NO5S/c1-11-9-14(15(20(24)25)10-12(11)2)18(23)22-19-17(21(26)27-3)13-7-5-4-6-8-16(13)28-19/h14-15H,4-10H2,1-3H3,(H,22,23)(H,24,25)/p-1
C21H26NO5S404.50041100

Advertisement